Company News
BioArctic, Eli Lilly Sign $30M BrainTransporter Deal
BioArctic AB and Eli Lilly entered a research collaboration to merge BrainTransporter technology with an undisclosed Lilly neurodegeneration drug candidate.
BioArctic will receive $30 million upfront
